Roche Diagnostics Korea said Friday that it donated 15 million won to the Korea Association for Prevention of Child Abuse and Neglect, to support children who have suffered from child abuse and provide parental education.The firm said it got the funds from donations made by its employees from Roche Pharmaceutical and Roche Diagnostics to the Roche Children’s Walk event hosted as a charity walk
Hana Pharm said Thursday that it is conducting phase 3 trials for a new sedative anesthetic agent called remimazolam (HNP-2001).The ultrashort-acting anesthetic has proved to have all the advantages of existing anesthetics such as propofol and midazolam while having an excellent sedative effect, rapid recovery, and low respiratory suppression side effects. It is also hydrolyzed rapidly in the
Boryung BioPharm said Thursday it launched its rapid diagnostic kit for the flu, called the “Flu Fast.”Flu Fast is a device that collects specimens from patients with influenza symptoms and identifies influenza types A and B using the immunochromatography method.Immunochromatography is an antigen detection based on an indirect fluorescence method detecting an antibody that specifically rea
Korean researchers have found a new drug candidate that maximizes the effect of killing acute leukemia cells when used in combination with other therapies.The team led by Professors Jo Jae-cheol and Choi Yun-suk from Ulsan University Hospital have discovered "Rhein," a substance that is effective in treating acute leukemia while searching for various clinical and anti-cancer drug substances.
Pictures and videos regarding suicide increased 3,728 percent this year to over 8,000 posts, from 210 posts in 2017. About 84 percent of the content related to self-harm, such as cutting.The Ministry of Health and Welfare, Korean National Police Agency, and the Korea Suicide Prevention Center have been work to secure an online “life-respecting” culture by running an interactive online suicide
Ildong Pharmaceutical said Thursday that it would enter a strategic alliance with Sandoz, a division of global pharmaceutical Novartis, to cooperate in product licensing and sales in the Asia-Pacific region.Ildong Pharmaceutical CEO Yoon Woong-sub and Sandoz’ Cluster Head of ASEAN and North Asia Francis Vaillant attended the ceremony to sign the memorandum of understanding. The MoU pertains to
Dong-A ST said Thursday it signed a development and sales licensing agreement with gene and cell therapy developing biopharmaceutical firm Takara Bio in Tokyo Wednesday for an oncolytic virus therapy called the Can-erpaturev (C-REV). Under the accord, Dong-A ST will get exclusive rights to develop and sell the investigational oncolytic virus therapy in Korea, which Takara Bio is dev
More and more Korean pharmaceuticals are jumping into developing new drugs, raising the number of clinical trials done in Korea in the past five years. “More domestic pharmaceutical companies seem to be focusing on developing new drugs. The number of phase 1 and 2 trials is also increasing because Korea has been raising its competency regarding clinical trials,” said an official at
Bridge Biotherapeutics, also known as BridgeBio, said Thursday it presented the results of a preclinical trial on BBT-877, an investigational idiopathic pulmonary fibrosis treatment, at the IPF Summit 2018 in San Francisco, which kicked off on Monday.Bridge Biotherapeutics is a Korean biopharmaceutical firm specializing in new drug development.LegoChem Biosciences first discovered BBT-877
Boehringer Ingelheim Korea said Wednesday it would present nine sub-analyses from the RE-DUAL PCI trial and the GLORIA-AF Registry Program, at the upcoming European Society of Cardiology (ESC) Congress 2018.The ESC Congress, hosted by the European Society of Cardiology, will open in Munich, Germany, on Aug. 25 and continue through Aug. 29.The primary data from the studies have led to a
Rare disease specialty biopharmaceutical firm Shire Korea said Wednesday it got the Ministry of Food and Drug Safety’s approval for its short bowel syndrome treatment Gattex (teduglutide) Friday.Gattex is the first treatment that won approval for short bowel syndrome in Korea. People over one year of age who have been relying on existing total parenteral nutrition (TNP) can now use the the
A lawmaker is working to get medical workers who die in the midst of transporting patients via helicopter the honorary rights to be buried in the National Cemetery. Rep. Park Kwang-on of the ruling Democratic Party of Korea said Tuesday he would submit a bill to revise the law related to establishing and operating the National Cemetery to this end."Saving people at the front of
Daiichi Sankyo Korea published the first real-world data on Koreans for its new oral anti-coagulant NOAC Lixiana (edoxaban) in the Journal of the American College of Cardiology Tuesday."As the only NOAC treatment developed in Asia, Lixiana is expected to remain firmly established as an optimal anticoagulant for Asians, including Koreans,” Daiichi Sankyo Korea CEO Kim Dae-jung said.Prof
Sanofi Pasteur and the Korean Sport and Olympic Committee (KSOC) have vaccinated the national squad for the 2018 Asian Games held in Palembang and Jakarta, against Japanese encephalitis.Officials vaccinated the national squad in July at the medical center in the Jincheon National Sports Village in North Chungcheong Province against one of the most dangerous infectious diseases. More than 1,000
Catholic University of Korea, Seoul St. Mary's Hospital has developed a new diagnostic system to quickly diagnose hepatitis within 20 minutes using a small amount of blood.Blood is a useful resource in emergency situations or at medical institutions that do not have the large diagnostic equipment, considering it can be used immediately for tests without the need for any preprocessing such as m
Patients with high-grade salivary gland cancer usually suffer unfavorable prognosis. Those with early-stage disease, however, can expect to have an excellent prognosis showing more than a 90 percent survival rate, with just surgery and adjuvant radiation, a local research team found.Salivary gland cancer is rare cancer affecting 1.4 people out of 100,000. If the disease is diagnosed late,
GC Cell said Friday that it got an orphan drug designation from the U.S. Food and Drug Administration for its anticancer immunotherapy Immuncell-LC to treat glioblastoma, the most aggressive cancer that begins in the brain.The Korean pharmaceutical firm won approval for Immuncell-LC to treat liver cancer from the Ministry of Food and Drug Safety in 2007.Immuncell-LC is a customized ant
The Korean branch of Merck said Monday that it got a patent for the use of paired CRISPR nickases from the Australian Patent Office.Paired nickases represent a significant step in increasing safety by improving CRISPR’s ability to fix diseased genes while not affecting healthy ones. Paired CRISPR nickase methods build on other technologies in Merck’s CRISPR patent portfolio, including CRIS
The Korea Centers for Disease Control and Prevention will now allow Koreans to get vaccination confirmation documents in English for free online starting next Monday.“We expect the new step will help reduce the burdens of issuing administrative documents and direct visits of applicants and guardians to public health centers, as they will be able to get English vaccination confirmation document
Amid the increasing number of patients attacking medical workers in emergency rooms of late, a recent survey shows eight out of 10 Korean doctors have experienced violence firsthand by their patients.According to InterMD, an information and knowledge sharing service for doctors, the survey of 1,750 doctors indicated that 1,321 doctors had experienced violence from their patients at hospitals.